1. Zhang, Hao, He, Jialin, Dai, Ziyu, Zhang, Liyang, Cheng, Quan. 2021. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas. In Frontiers in immunology, 12, 628966. doi:10.3389/fimmu.2021.628966. https://pubmed.ncbi.nlm.nih.gov/33664747/
2. Ji, Qiankun, Tu, Zewei, Liu, Junzhe, Zhu, Xingen, Huang, Kai. 2024. RUNX1-PDIA5 Axis Promotes Malignant Progression of Glioblastoma by Regulating CCAR1 Protein Expression. In International journal of biological sciences, 20, 4364-4381. doi:10.7150/ijbs.92595. https://pubmed.ncbi.nlm.nih.gov/39247813/
3. Chen, Yu, He, Jialin, Chen, Rui, Zhang, Hao, Cheng, Quan. 2022. Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy. In Frontiers in immunology, 13, 881722. doi:10.3389/fimmu.2022.881722. https://pubmed.ncbi.nlm.nih.gov/36003400/
4. Higa, Arisa, Taouji, Said, Lhomond, Stéphanie, Schekman, Randy, Chevet, Eric. 2014. Endoplasmic reticulum stress-activated transcription factor ATF6α requires the disulfide isomerase PDIA5 to modulate chemoresistance. In Molecular and cellular biology, 34, 1839-49. doi:10.1128/MCB.01484-13. https://pubmed.ncbi.nlm.nih.gov/24636989/
智鼠故事 
